Sanofi Digital Transformation Strategy Analysis Report 2025: Accelerators, Innovation Programs, Incubators, ICT, Technology Initiatives, Partnerships, Investments, Acquisitions, Network Map

Dublin, Feb. 25, 2026 (GLOBE NEWSWIRE) -- The "Enterprise Tech Ecosystem Series: Sanofi S.A. 2025" company profile has been added to ResearchAndMarkets.com's offering.

The report provides insights into company's tech activities, including its digital transformation strategies, its innovation programs, and its technology initiatives.

Sanofi is a healthcare company, which is engaged in the discovery, development, manufacturing, and marketing of an array of medicines and vaccines. Its portfolio includes medicines for the treatment of cancer, rare diseases, multiple sclerosis; human vaccines for protection against various bacterial and viral diseases; and other products.

Sanofi's R&D efforts focus on advancing a combination drug to increase the effectiveness of treatments and on advancing the formulation of new biologics to produce precision medicines. It has an operational presence in Europe, the Americas, Africa, Asia-Pacific, and the Middle East.

The company also offers consumer healthcare products for digestion; allergy; cough, cold, flu and sinus; pain; women's health; and vitamins, minerals, and supplements.

Report Scope

Reasons to Buy

Key Topics Covered:

Companies Featured

For more information about this company profile visit https://www.researchandmarkets.com/r/hmk596

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.